Literature DB >> 911606

Plasma prednisolone levels from enteric and non-enteric coated tablets estimated by an original technique.

P J Morrison, I D Bradbrook, H J Rogers.   

Abstract

1 A quantitative thin layer chromatographic technique for the estimation of plasma prednisolone levels has been devised with a minimum level of estimation of 10 ng/ml. 2 A comparative study of the absorption of 5 and 10 mg prednisolone from enteric and non-enteric coated tablets (5 mg) was carried out in healthy subjects. 3 Mean plasma half-life and peak plasma concentrations obtained from the non-enteric coated preparation agree well with previous studies in normal subjects reported by other investigators using competitive protein binding or radioimmunoassay techniques. Intersubject variability in bioavailability was noted. 4 Enteric coating increased the lag time before prednisolone appeared in the blood but did not alter the bioavailability of prednisolone compared to the equivalent dose of the non-enteric coated tablet.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 911606      PMCID: PMC1429147          DOI: 10.1111/j.1365-2125.1977.tb00792.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Comparative bioavailabilities from truncated blood level curves.

Authors:  E G Lovering; I J McGilveray; I McMillan; W Tostowaryk
Journal:  J Pharm Sci       Date:  1975-09       Impact factor: 3.534

2.  Prevention of peptic ulceration during corticosteroid therapy.

Authors:  H F WEST
Journal:  Br Med J       Date:  1959-10-10

3.  Absorption of enteric and non-enteric coated prednisolone tablets.

Authors:  B Hulme; V H James; R Rault
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

4.  A radioimmunoassay method for prednisolone: comparison with the competitive protein binding method.

Authors:  J Chakraborty; J English; V Marks; M C Dumasia; D J Chapman
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

5.  Simultaneous competitive protein binding assay for cortissol, cortisone, and prednisolone in plasma, and its clinical application.

Authors:  A K Turner; C J Carroll; J L Pinkus; D Charles; S C Chattoraj
Journal:  Clin Chem       Date:  1973-07       Impact factor: 8.327

6.  Effect of alternate-day, single-dose, corticosteroid therapy on pituitary-adrenal function.

Authors:  M E Carter; V H James
Journal:  Ann Rheum Dis       Date:  1972-09       Impact factor: 19.103

7.  Patterns of plasma levels of prednisolone after oral administration in man.

Authors:  R Leclercq; G Copinschi
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

8.  Pharmacokinetic criteria for the evaluation of retard formulations.

Authors:  J Meier; E Nüesch; R Schmidt
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

9.  Measurement of plasma prednisolone in man.

Authors:  C G Wilson; R Ssendagire; C S May; J W Paterson
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

10.  Prednisolone levels in the plasma and urine: a study of two preparations in man.

Authors:  J English; J Chakraborty; V Marks; D J Trigger; A G Thomson
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

View more
  15 in total

1.  Variation in plasma prednisolone concentrations in renal transplant recipients given enteric-coated prednisolone.

Authors:  R G Henderson; T Wheatley; J English; J Chakraborty; V Marks
Journal:  Br Med J       Date:  1979-06-09

Review 2.  Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: a review.

Authors:  J G Gambertoglio; W J Amend; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1980-02

3.  Pharmacokinetics of intravenous and oral prednisolone.

Authors:  S Al-Habet; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335

4.  Concurrent administration of cimetidine and enteric-coated prednisolone: effect on plasma levels of prednisolone.

Authors:  P J Morrison; H J Rogers; I D Bradbrook; C Parsons
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

5.  Malabsorption of prednisolone from enteric-coated tablets after ileostomy.

Authors:  S Al-Habet; H C Kinsella; H J Rogers; J R Trounce
Journal:  Br Med J       Date:  1980-09-27

6.  Investigation of a case of prednisolone malabsorption.

Authors:  T G Mant
Journal:  Postgrad Med J       Date:  1979-06       Impact factor: 2.401

7.  Prednisolone absorption in coeliac disease.

Authors:  M E Pickup; F Farah; J R Lowe; J S Dixon; C O Record
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

8.  Continuous nebulised salbutamol and oral once a day prednisolone in status asthmaticus.

Authors:  M Singh; L Kumar
Journal:  Arch Dis Child       Date:  1993-10       Impact factor: 3.791

9.  Alternate day corticosteroid causes alternate day hyperglycaemia.

Authors:  M A Greenstone; A B Shaw
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

10.  Effects of prednisolone on angiotensin converting enzyme activity.

Authors:  J E Roulston; G I O'Malley; J G Douglas
Journal:  Thorax       Date:  1984-05       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.